A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 9, 2004, Pages 975-982

  Rodriguez Stanley, S ^a   Ciociola, A A ^b   Zubaidi, S ^a   Proskin, H M ^c   Miner Jr , P B ^a  

^a Oklahoma Foundation for Digestive Research   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c Howard M Proskin & Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; PLACEBO; RANITIDINE;

ACID SECRETION; ADULT; ARTICLE; BAROSTAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ESOPHAGUS FUNCTION; FEMALE; HEARTBURN; HUMAN; MALE; MECHANICAL STIMULATION; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SENSORY ANALYSIS; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; ESOPHAGUS; FEMALE; GASTRIC ACID; HEARTBURN; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; RANITIDINE; TREATMENT OUTCOME;

EID: 9944233066     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02217.x     Document Type: Article

References (15)

1. Rodriguez SL, Earnest DL, Greenwood-Van Meerveld B, Maton P, Miner PB, Robinson M. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: 628-31.
2. Drossman DA. Rome II: The Functional Gastrointestinal Disorders. 2nd edn. Degnon Associates, McLean, VA, USA, 2000.
3. Li BY, Nalwalk JW, Barker LA, Cumming P, Parsons ME, Hough LB. Characterization of the antinociceptive properties of cimetidine and a structural analog. J Pharmacol Exp Ther 1996; 276: 500-8.
4. Coruzzi G, Bertaccini G. Histamine receptors in the lower esophageal sphincter (LES). Agents Actions Suppl 1982; 1-2: 157-61.
5. Fujinuma S, Kamikawa Y, Shimo Y. Pharmacological characterization of the histamine receptor in the isolated muscularis mucosae of the guinea-pig oesophagus. Br J Pharmacol 1985; 86: 619-25.
6. Hough LB, Glick SD, Su K. A role for histamine and histamine H2-receptors in non-opiate footshock-induced analgesia. Life Sci 1985; 36: 859-66.
7. Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers. Am J Gastroenterol 1986; 81: 1167-70.
8. Netti C, Guidobono F, Sibilia V, Villa I, Cazzamalli E, Pecile A. Central effects of histamine H2-receptor agonists and antagonists on nociception in the rat. Agents Actions Suppl 1988; 23: 247-9.
9. Mansfield LE. The role of antihistamine therapy in vascular headaches. J Allergy Clin Immunol 1990; 86: 673-6.
10. Rumore MM, Schlichting DA. Clinical efficacy of antihistamines as analgesics. Pain 1986; 25: 7-22.
11. Owen SM, Sturman G, Freeman P. Modulation of morphine-induced antinociception in mice by histamine HS-receptor ligands. Agents Actions Suppl 1994; 41: C62-3.
12. Marrero JM, de Caestecker JS, Maxwell JD. Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease. Gut 1994; 35: 447-50.
13. Mayrand S, Diamant NE. Measurement of human esophageal tone in vivo. Gastroenterology 1993; 105: 1411-20.
14. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
15. Rodriguez-Stanley S, Zubaidi S, Ciociola A, Miner P. Wide spectrum of symptoms produced by barostat balloon distention of the esophagus in patients presenting with varied upper GI complaints. Am J Gastroenterol 2002; 97: A72.